Global thyroid pharma economics: T3 meds

Here’s an update on prices in some locations of the world, and Canada, for synthetic T3 medication, known by the chemical name liothyroinine. UNITED KINGDOM & GREECE A Daily Mail article published May 27, 2019 reported the prices for T3 / Liothyronine pills in the UK over time, and today in Greece: 20-25 mcg / day, 1 month UK, 2007, 28 x 20 mcg = £4.46 GBP  = $ 7.61 CAD UK, 2019, 28 x 20 mcg = £204.39 GBP = $348.77 CAD GREECE, 2019, 30 x 25 mcg = £1 GBP = $1.71 CAD Quotations from the article: “Going …

Continue Reading

A Thyroid Patients Manifesto

Manifesto: “a written statement declaring publicly the intentions, motives, or views of its issuer” (Merriam-Webster) I humbly offer the following manifesto for us as thyroid patients. WE, as citizens maintained by thyroid hormone therapy, declare our equal rights to health and well being as other citizens with complex chronic health conditions like diabetes, cancers, and heart disease. We have the right to agency and choice within our thyroid therapy. We are not just patients to be passively managed according to physician choices. We ought to have access to patient-centered, collaborative care in partnership with doctors who truly respect all the …

Continue Reading